Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors

Appointment effective as of September 14, 2023; Zeev Bronfeld to retire from the Board of Directors CARMIEL, Israel, Sept. 12, 2023 (Healthcare Sales & Marketing Network) Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company ... Biopharmaceuticals, Personnel Protalix BioTherapeutics, ProCellEx
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news